Factors predicting outcome in patients with primary refractory intermediate grade lymphoma (IGL) eligible for high dose chemoradiotherapy (HDT) and autologous stem cell transplant (ASCT) Meeting Abstract


Authors: Kewalramani, T.; Hedrick, E. E.; Donnelly, G. B.; Satagopan, J. M.; Hunte, S.; Priovolos, A.; Zelenetz, A. D.; Nimer, S. D.; Moskowitz, C. H.
Abstract Title: Factors predicting outcome in patients with primary refractory intermediate grade lymphoma (IGL) eligible for high dose chemoradiotherapy (HDT) and autologous stem cell transplant (ASCT)
Meeting Title: 41st Annual Meeting of the American Society of Hematology (ASH)
Journal Title: Blood
Volume: 94
Issue: 10 Suppl. 1 Pt. 1
Meeting Dates: 1999 Dec 3-7
Meeting Location: New Orleans, LA
ISSN: 0006-4971
Publisher: American Society of Hematology  
Date Published: 1999-11-15
Start Page: 173a
Language: English
ACCESSION: WOS:000083790300804
PROVIDER: wos
PUBMED: 10590715
Notes: Meeting Abstract: 755 -- Source: Wos
MSK Authors
  1. Craig Moskowitz
    371 Moskowitz
  2. Jaya M Satagopan
    137 Satagopan
  3. Eric E Hedrick
    16 Hedrick
  4. Andrew D Zelenetz
    547 Zelenetz
  5. Stephen D Nimer
    339 Nimer
  6. Sonia L Hunte
    3 Hunte